Bullish Case: Known: XRX is ~$3.14 and the XRX vol surface is highly skewed—very elevated IV concentrated at deep-downside strikes, while near-the-money IV is comparatively lower and the term structure looks flat. Compared with SPY’s smoother, lower IV “sheet,” this suggests idiosyncratic tail pricing more than macro fear. Inferred: the return surface shows recurring mean-reversion bands. If Jul17/next earnings bring any credible deleveraging (warrants/cash/contracts), upside bounce becomes more likely (modestly).

Bearish Case: Known: XRX recent action is flat, yet the XRX volatility surface implies persistent left-tail risk (extreme IV at low strikes) unlike SPY’s smoother macro vol. Inferred from the XRX return surface: probability mass leans toward negative % returns across holding windows, so downside drift remains plausible. Helium’s price forecast is slightly bearish (-2.26%) with near-zero directional correlation (-0.1). Calibration: my earlier bankruptcy-before-2027 odds (30–38%) look too high versus current market pricing (~4%), but dilution/restructuring risk is still uncertain and could re-ignite a leg down.

Potential Outcomes:

1. ~22%: Earnings/contract + warrant deleveraging ⇒ mean-revert; falsifiable by 8-K/10-Q raising 2026 FCF or explicit covenant relief.
2. ~46%: Drift/flat-to-down ⇒ -10% to -25%; falsifiable by guidance cut or liquidity/margin deterioration.
3. ~18%: Restructuring/dilution without filing ⇒ -35% to -55%; falsifiable by debt-for-equity terms or material new issuance.
4. ~4%: Bankruptcy/Chapter 11 ⇒ -70%+; falsifiable by filing or covenant breach announcement.
5. ~10%: Speculative squeeze ⇒ transient +25%+; falsifiable by abnormal option OI/volume + price spike near expiries (Jul17).

Trading Oracle: Sign Up to access trading oracle trade ideas.

June 24, 2026